| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 253,975 | 217,944 | 195,251 | 230,421 | | Cost of Revenue | 191,202 | 177,555 | 151,881 | 241,602 | | | Gross Profit | 62,773 | 40,389 | 43,370 | (11,181) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,230 | 22,454 | 24,569 | 26,187 | | Non Recurring |
-
|
-
|
-
| 47,073 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,543 | 17,935 | 18,801 | (84,441) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,687) | (885) | 2,511 | 8,337 | | Earnings Before Interest And Taxes | 27,299 | 17,050 | 21,312 | (76,104) | | Interest Expense | (6,588) | 3,411 | 3,177 | 3,812 | | Income Before Tax | 33,887 | 13,639 | 18,135 | (79,916) | | Income Tax Expense | 11,075 | 4,429 | 6,765 | (20,632) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,812 | 9,210 | 11,370 | (59,284) | | | Non-recurring Events | | Discontinued Operations | (150) | (35) | (208) | (613) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,662 | 9,175 | 11,162 | (59,897) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $22,662 | $9,175 | $11,162 | ($59,897) |
|
1.00% Nasdaq 0.00%
Income Statement
